100 related articles for article (PubMed ID: 1191768)
1. [Effect of reversible inhibitors on the thermal denaturation of cholinesterases].
Tonkopiĭ VD; Padinker EB
Biull Eksp Biol Med; 1975 Apr; 79(4):51-2. PubMed ID: 1191768
[TBL] [Abstract][Full Text] [Related]
2. [Interaction of reversible inhibitors with the catalytic centers and allosteric sites of cholinesterases].
Tonkopiĭ VD; Prozorovskiĭ VB; Suslova IM
Biull Eksp Biol Med; 1976 Aug; 82(8):947-50. PubMed ID: 1026294
[TBL] [Abstract][Full Text] [Related]
3. [Determination of cholinesterase activity in animal tissues following treatment with reversible inhibitors].
tonkopiĭ VD; Savateev NV; Brestkin AP; Panov AN
Dokl Akad Nauk SSSR; 1972 Nov; 207(3):736-8. PubMed ID: 4642922
[No Abstract] [Full Text] [Related]
4. Actions of tacrine and galanthamine on histamine-N-methyltransferase.
Taraschenko OD; Barnes WG; Herrick-Davis K; Yokoyama Y; Boyd DL; Hough LB
Methods Find Exp Clin Pharmacol; 2005 Apr; 27(3):161-5. PubMed ID: 15834447
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective effects of galanthamine and tacrine against glutamate neurotoxicity.
Takada-Takatori Y; Kume T; Sugimoto M; Katsuki H; Niidome T; Sugimoto H; Fujii T; Okabe S; Akaike A
Eur J Pharmacol; 2006 Nov; 549(1-3):19-26. PubMed ID: 16996497
[TBL] [Abstract][Full Text] [Related]
6. [Galanthamine interaction with mouse brain acetylcholinesterase in in vivo experiments].
Tonkopiĭ VD; Prozorovskiĭ VB
Biull Eksp Biol Med; 1976 Jul; 82(7):823-5. PubMed ID: 953343
[TBL] [Abstract][Full Text] [Related]
7. [Effect of securinine and galanthamine on cholinesterase activity].
Aoyagi Y; Maki Y; Yamazoe S
Igaku To Seibutsugaku; 1965 Dec; 71(6):349-51. PubMed ID: 4380182
[No Abstract] [Full Text] [Related]
8. [The effect of pH and reversible inhibitors on decarbamylation of acetylcholinesterase].
Kugusheva LI; Rozengart VI; Sherstobitov OE
Ukr Biokhim Zh (1978); 1991; 63(3):29-35. PubMed ID: 1926583
[TBL] [Abstract][Full Text] [Related]
9. [Mechanism of the hypothermic action of reversible cholinesterase inhibitors].
Tonkopiĭ VD
Farmakol Toksikol; 1975; 38(2):141-4. PubMed ID: 1227897
[TBL] [Abstract][Full Text] [Related]
10. In vivo kinetics of blood cholinesterase inhibition by 9-amino-1, 2, 3, 4-tetrahydroacridine, its 7-methoxy derivative and physostigmine in rats.
Bajgar J; Fusek J; Patocka J; Hrdina V
Physiol Bohemoslov; 1979; 28(1):31-4. PubMed ID: 155828
[TBL] [Abstract][Full Text] [Related]
11. Choline pivaloyl ester strengthened the benefit effects of Tacrine and Galantamine on electroencephalographic and cognitive performances in nucleus basalis magnocellularis-lesioned and aged rats.
Rispoli V; Marra R; Costa N; Scipione L; Rotiroti D; De Vita D; Liberatore F; Carelli V
Pharmacol Biochem Behav; 2006 Jul; 84(3):453-67. PubMed ID: 16859739
[TBL] [Abstract][Full Text] [Related]
12. [Characteristics of galanthamine as a reversible inhibitor of cholinesterase].
Vasilenko ET; Tonkopiĭ VD
Biokhimiia; 1974; 39(4):701-3. PubMed ID: 4441566
[No Abstract] [Full Text] [Related]
13. [Effect of reversible inhibitors on the reaction capacity of functional portions of the active center of acetylcholinesterase].
Tonkopiĭ VD; Ardab'eva TV
Biull Eksp Biol Med; 1978 Oct; 86(10):441-4. PubMed ID: 708873
[TBL] [Abstract][Full Text] [Related]
14. [Effect of cholinergic preparations on leukocyte migration].
Baryshnikov II; Smirnova OI
Farmakol Toksikol; 1981; 44(1):85-7. PubMed ID: 7262305
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of 6beta-D-glucosyl and 6-nitroxy (-)-galanthamine derivatives as acetylcholinesterase inhibitors.
Perissutti E; Fiorino F; Severino B; Frecentese F; Massarelli P; Nencini C; Santagada V; Caliendo G
Pharmazie; 2007 Jun; 62(6):403-5. PubMed ID: 17663183
[TBL] [Abstract][Full Text] [Related]
16. [Joint action of reversible and irreversible cholinesterase inhibitors on neuromuscular transmission in the rat diaphragm].
Drabkina TM; Kuleshov VI; Matiushkin DP; Sanotskiĭ VI; Seĭ TP
Nauchnye Doki Vyss Shkoly Biol Nauki; 1983; (9):36-40. PubMed ID: 6315088
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of purinergic neurotransmission by galantamine and other acetylcholinesterase inhibitors in the rat vas deferens.
Caricati-Neto A; D'angelo LC; Reuter H; Hyppolito Jurkiewicz N; Garcia AG; Jurkiewicz A
Eur J Pharmacol; 2004 Oct; 503(1-3):191-201. PubMed ID: 15496314
[TBL] [Abstract][Full Text] [Related]
18. Galantamine is an allosterically potentiating ligand of neuronal nicotinic but not of muscarinic acetylcholine receptors.
Samochocki M; Höffle A; Fehrenbacher A; Jostock R; Ludwig J; Christner C; Radina M; Zerlin M; Ullmer C; Pereira EF; Lübbert H; Albuquerque EX; Maelicke A
J Pharmacol Exp Ther; 2003 Jun; 305(3):1024-36. PubMed ID: 12649296
[TBL] [Abstract][Full Text] [Related]
19. [On the molecular mechanism of action of galanthamine, an antagonist of nondepolarizing muscle relaxants (author's transl)].
Schuh FT
Anaesthesist; 1976 Sep; 25(9):444-8. PubMed ID: 135519
[TBL] [Abstract][Full Text] [Related]
20. Tacrine based human cholinesterase inhibitors: synthesis of peptidic-tethered derivatives and their effect on potency and selectivity.
Butini S; Guarino E; Campiani G; Brindisi M; Coccone SS; Fiorini I; Novellino E; Belinskaya T; Saxena A; Gemma S
Bioorg Med Chem Lett; 2008 Oct; 18(19):5213-6. PubMed ID: 18786825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
